A multicenter survey of patients decision making preferences in patients with advanced cancers

• Register: CTRI
• Last refreshed on: 24 November 2021
• Main ID: CTRI/2017/11/010481
• Date of registration: 14-11-2017
• Prospective Registration: No
• Primary sponsor: Department of Atomic Energy Clinical Trials Centre
• Public title: A multicenter survey of patients decision making preferences in patients with advanced cancers
• Scientific title: Patients decisional control preferences in the Palliative Care setting: a multicenter survey
• Date of first enrolment: 06-12-2014
• Target sample size: 100
• Recruitment status: Completed
• URL: http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=12188
• Study type: Observational
• Study design: Other; Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable
• Phase: N/A

Countries of recruitment

Argentina, Brazil, Chile, India, Jordan, Philippines, Singapore, South Africa, Spain, United States of America

Contacts

• Name: Dr MaryAnn Muckaden
• Affiliation: Tata Memorial Hospital

• Name: Dr MaryAnn Muckaden
• Affiliation: Tata Memorial Hospital

Key inclusion & exclusion criteria

Inclusion criteria: 1. Patient with advanced cancer (locally recurrent or metastatic).

2. Patient is 18 years of age or older (as the assessment tools used in this study have not been validated in the pediatric population).

3. Patient with normal cognitive status as determined by the interviewer and by her/his ability to understand the nature of the study and consent process.

4. Patient willing to participate in the study and sign informed consent.

5. Patient seen by the palliative care team consultation for atleast one visit.

6. Patient has resided in the study country for at least 5 years


Exclusion criteria: 1. Patient refusal to participate in the study.

Age minimum:
Age maximum:
Gender:

Health Condition(s) or Problem(s) studied

Health Condition 1: C00-D49- Neoplasms

Intervention(s)

Intervention1: NIL: NIL

Primary Outcome(s)

To describe the proportions of passive decision making for individual countries throughout the world.Timepoint: at the time of outpatients consultation of patient in department of Palliative Medicine

Secondary Outcome(s)

To identify the factors that influence patient satisfaction with the decision-making process.Timepoint: at the time of outpatients consultation of patient in department of Palliative Medicine

To determine the agreement between patientsâ?? decisional control preferences and their self-reported actual decision-making experiences regarding cancer care.Timepoint: at the time of outpatients consultation of patient in department of Palliative Medicine

To compare the proportion of passive decision making in developed and developing countries.

Timepoint: at the time of outpatients consultation of patient in department of Palliative Medicine

To identify associations among patients decisional control preferences with their socio demographic and clinical characteristics.Timepoint: at the time of outpatients consultation of patient in department of Palliative Medicine

To determine patientsâ?? level of understanding of their illness and prognosis.Timepoint: at the time of outpatients consultation of patient in department of Palliative Medicine

Secondary ID(s)

1273 (Version 1.0 dated 06.03.2013)

Source(s) of Monetary Support

Department of Atomic Energy Clinical Trials Centre, Tata Memorial Centre, Dr E. Borges Road, Parel, Mumbai -400012

Ethics review

Status: Approved
Approval date: 16/10/2014
Contact:

Institutional Ethics Committee

Results

• Date Completed: 23/09/2016